Ray Dalio acquired 60.2 Thousand Haemonetics shares worth $4.94 Million. That's 0.03% of their equity portfolio (355th largest holding). The first Haemonetics trade was made in Q2 2021. Since then Ray Dalio bought shares five more times and sold shares on four occasions. The stake costed the investor $4.03 Million, netting the investor a gain of 22% so far.